NCT03441633View on ClinicalTrials.gov

Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf)

CompletedOBSERVATIONAL

Enrollment

51,690

Participants

Timeline

Start Date

February 18, 2016

Primary Completion Date

March 8, 2017

Study Completion Date

March 8, 2017

Conditions

Atrial Fibrillation

Interventions

DRUG

apixaban

current or new medication

DRUG

dabigatran

current or new medication

DRUG

VKA

current or new medication

DRUG

rivaroxaban

current or new medication

Trial Locations (1)

8007

IDIAP Jordi Gol, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY